Scholar
IQ
Help
Try ScholarIQ free
Home
Papers
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Upload Records
Snowball Search
Search OpenAlex
About the database
ScholarIQ
answers from OpenAlex
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Paper
Citations, authors & open-access status
2,543
Citations
2,018
Year
closed
OA Status
IDs:
DOI
PMID
OpenAlex
Related on ScholarIQ
The Lancet Oncology
Journal
Hepatocellular Carcinoma Treatment and Prognosis
Topic
Hepatocellular Carcinoma Treatment and Prognosis
Topic
Cancer Immunotherapy and Biomarkers
Topic
470M+ articles · free account